PeRiphEral Nerve StImulation REgistry For Intractable Migraine Headache

Study Objective :

The primary objective of the registry is to evaluate the long-term safety and performance of neurostimulation for the treatment of intractable chronic migraine as well as to detect infrequent complications or problems only apparent in “real-world” practice.

Patients will be enrolled post-implant and followed for 24 months. Data are collected at enrollment (within 30 days of device implant), and routine care follow-up visits during the 24 month post-implant period.

Participation conditions

• Patient is 18 years of age or older.
• Patient has signed and received a copy of the Informed Consent form;
• Patient has been implanted with a CE approved implantable neurostimulation system for the treatment of intractable chronic migraine:
• Patient diagnosed with chronic migraine (15 or more days per month with headache lasting at least 4 hours per day)
• Patient has failed three or more preventative drugs for treatment of their migraine
• Patient as at least moderate disability determined using a validated migraine disability instrument [e.g., MIDAS >11 or HIT-6 >56]

Neurosurgery unit of Center Hospital of Luxembourg